Adagene Stock Performance

ADAG Stock  USD 1.81  0.04  2.26%   
The firm shows a Beta (market volatility) of -0.96, which signifies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Adagene are expected to decrease slowly. On the other hand, during market turmoil, Adagene is expected to outperform it slightly. At this point, Adagene has a negative expected return of -0.15%. Please make sure to confirm Adagene's mean deviation, jensen alpha, potential upside, as well as the relationship between the standard deviation and treynor ratio , to decide if Adagene performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Adagene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
1
ADAG Stock Rises Amid Biotech Sector Gains
12/24/2024
2
Adagene to Host Virtual KOL Event to Discuss Anti-CTLA-4 SAFEbody ADG126 in AdvancedMetastatic Microsatellite-Stable Colorectal Cancer on January 25, 2025
01/14/2025
3
Adagene to Announce Updated Data from Phase 1b2 Study of Muzastotug in Combination with KEYTRUDA in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium
01/21/2025
4
Adagene to present new ADG126 clinical data at ASCO-GI - MSN
01/22/2025
5
H.C. Wainwright lifts Adagene stock target to 8 on ASCO data - Investing.com
01/27/2025
6
Morgan Stanley Downgrades Adagene to Equal Weight From Overweight -January 31, 2025 at 0757 am EST - Marketscreener.com
01/31/2025
7
Adagene Inc. Short Interest Update - MarketBeat
02/13/2025
8
Adagene Announces Investigator Initiated Phase 2 Trial for Neoadjuvant Muzastotug in ...
02/27/2025
9
Adagene to Present at Leerinks Global Healthcare Conference 2025
03/06/2025
10
Adagene to Present at 11th Annual Immuno-Oncology 360 Summit
03/13/2025
Begin Period Cash Flow143.8 M
  

Adagene Relative Risk vs. Return Landscape

If you would invest  204.00  in Adagene on December 18, 2024 and sell it today you would lose (23.00) from holding Adagene or give up 11.27% of portfolio value over 90 days. Adagene is currently does not generate positive expected returns and assumes 3.3423% risk (volatility on return distribution) over the 90 days horizon. In different words, 29% of stocks are less volatile than Adagene, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Adagene is expected to under-perform the market. In addition to that, the company is 3.91 times more volatile than its market benchmark. It trades about -0.04 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.02 per unit of volatility.

Adagene Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Adagene's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Adagene, and traders can use it to determine the average amount a Adagene's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0439

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsADAG

Estimated Market Risk

 3.34
  actual daily
29
71% of assets are more volatile

Expected Return

 -0.15
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.04
  actual daily
0
Most of other assets perform better
Based on monthly moving average Adagene is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adagene by adding Adagene to a well-diversified portfolio.

Adagene Fundamentals Growth

Adagene Stock prices reflect investors' perceptions of the future prospects and financial health of Adagene, and Adagene fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Adagene Stock performance.

About Adagene Performance

By analyzing Adagene's fundamental ratios, stakeholders can gain valuable insights into Adagene's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Adagene has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Adagene has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.19)(0.20)
Return On Capital Employed(0.32)(0.34)
Return On Assets(0.19)(0.20)
Return On Equity(0.31)(0.29)

Things to note about Adagene performance evaluation

Checking the ongoing alerts about Adagene for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Adagene help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Adagene generated a negative expected return over the last 90 days
Adagene may become a speculative penny stock
Adagene has high historical volatility and very poor performance
The company reported the previous year's revenue of 18.11 M. Net Loss for the year was (18.95 M) with profit before overhead, payroll, taxes, and interest of 10.18 M.
Adagene currently holds about 168.04 M in cash with (28.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Adagene has a frail financial position based on the latest SEC disclosures
Latest headline from finance.yahoo.com: Adagene to Present at 11th Annual Immuno-Oncology 360 Summit
Evaluating Adagene's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Adagene's stock performance include:
  • Analyzing Adagene's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Adagene's stock is overvalued or undervalued compared to its peers.
  • Examining Adagene's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Adagene's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Adagene's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Adagene's stock. These opinions can provide insight into Adagene's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Adagene's stock performance is not an exact science, and many factors can impact Adagene's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Adagene Stock analysis

When running Adagene's price analysis, check to measure Adagene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adagene is operating at the current time. Most of Adagene's value examination focuses on studying past and present price action to predict the probability of Adagene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adagene's price. Additionally, you may evaluate how the addition of Adagene to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stocks Directory
Find actively traded stocks across global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance